Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose PRP for moderate carpal tunnel syndrome
ChiCTR2400082817Phase 4Suspended
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of platelet-rich plasma in carpal tunnel syndrome (CTS) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: VAS score for numbness. Started Apr 2024; status: suspended.
02
Drugs
platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on ChiCTR2400082817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082817.